Test Code PDR Post Delivery Rhogam (Fetal Screen)
Synonyms
- Rosette test
- FMH Screen
Clinical Significance
The use of a test to detect large fetal-maternal hemorrhages is required in AABB standards for blood banks and transfusion services.
Methodology
A suspension of red blood cells from the D-Negative mother is mixed with reagent containing anti-D and is incubated for 5 minutes at room temperature. During incubation any minor population of D-positive cells are coated with anti-D. After incubation cells are washed to remove all unbound antibody and indicator cells are added. One antigen-binding site free to attach to an Rh antigen of the indicator cells. the red cell mixture is centrifuged and examined microscopically for mixed-field agglutination in the form of rosettes at low power. The indicator cells added after washing form rosettes around the individual cells leading to larger agglutinates for detection.
Sample Type
| Preferred Sample Type | |
|---|---|
| Lavender top - Packed RBCs | |
Centrifuge: Yes (In Blood Bank)
Specimen Stability
| Temperature | Time |
|---|---|
| Refrigerated (1-10°C) (store) | 48 hours |
Specimen Minimum Volume
0.5 mL
Result Reporting
| Normal |
|---|
| Negative |
| Abnormal |
|---|
| Positive* |
*Positive fetal screens reflex to a Kleihauer Betke
Rejection Criteria
- Samples not properly labeled (2 patient identifiers required)
- Grossly hemolyzed specimens
Availability
| Performed | STAT |
|---|---|
| 24/7 | Yes |
Performing Laboratory
MultiCare Yakima Memorial Hospital Laboratory
Lab Department
Blood Bank
CPT Code
85461
LOINC
33900-2 Fetal cell screen Rosette test QI (Bld)